SCHEMBL3911963

SCHEMBL3911963

O=S(=O)(O)CC(N1CCN(CCO)CC1)S(=O)(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
KMT2A Q03164 2/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
TERT O14746 1/20 0.31
HSD11B1 P28845 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
OPRD1 P41143 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5062392 0.86 CHRM2 (0.40) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL4239133 0.84 KMT2A (0.43) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL2490415 0.84 CHRM2 (0.40) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL126114 0.83 CHRM2 (0.42) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL5062396 0.81 CHRM2 (0.40) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL129496 0.80 CHRM2 (0.40) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL3089652 0.79 CHRM2 (0.39) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL4606042 0.79 CHRM2 (0.45) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL3414469 0.79 CHRM2 (0.39) CHRM2CHRM1ALDH1A1KDM4EKMT2A
SCHEMBL7084580 0.78 CHRM2 (0.41) CHRM2CHRM1ALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189937-B1 PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME MOLECULAR GERIATRICS CORP (US) 2009-03-18 EP disclosed
US-20080181883-A1 Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same APPLIED NEUROSOLUTIONS FORMALLY KNOWN AS MOLECULAR GERIATRICS CORPORATION 2008-07-31 US disclosed
US-20050272094-A1 Purified antigen for Alzheimer's disease and methods of obtaining and using same MOLECULAR GERIATRICS CORPORATION 2005-12-08 US disclosed
US-6864062-B2 Purified antigen for Alzheimer's disease and methods of obtaining and using same MOLECULAR GERIATRICS CORPORATION (US) 2005-03-08 US disclosed
US-20030113896-A1 Purified antigen for Alzheimer's disease and methods of obtaining and using same ZINKOWSKI RAYMOND P (US) 2003-06-19 US disclosed
EP-1189937-A1 PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME MOLECULAR GERIATRICS CORPORATION (US) 2002-03-27 EP disclosed
US-20020002270-A1 PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME MOLECULAR GERIATRICS CORPORATION 2002-01-03 US disclosed
WO-2000078807-A1 PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME MOLECULAR GERIATRICS CORPORATION (US) 2000-12-28 WO disclosed